Jinfeng Li

1.7k total citations
80 papers, 1.1k citations indexed

About

Jinfeng Li is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jinfeng Li has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 23 papers in Oncology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Jinfeng Li's work include Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (18 papers) and HER2/EGFR in Cancer Research (9 papers). Jinfeng Li is often cited by papers focused on Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (18 papers) and HER2/EGFR in Cancer Research (9 papers). Jinfeng Li collaborates with scholars based in China, Ethiopia and United States. Jinfeng Li's co-authors include Yunliang Wang, Yuntao Xie, Tianfeng Wang, Honglei Yin, Zhaoqing Fan, Bing Han, Yuzhen Zhang, Tao Ouyang, Benyao Lin and Kanliang Wang and has published in prestigious journals such as Cancer Research, Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Jinfeng Li

76 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinfeng Li China 18 474 454 191 160 117 80 1.1k
Esa Pitkänen Finland 23 238 0.5× 653 1.4× 201 1.1× 258 1.6× 119 1.0× 60 1.7k
Andrea Degasperi United Kingdom 13 496 1.0× 746 1.6× 234 1.2× 165 1.0× 57 0.5× 21 1.3k
Xuan Xiang China 21 592 1.2× 869 1.9× 235 1.2× 71 0.4× 64 0.5× 41 1.6k
Hugues Sicotte United States 19 259 0.5× 713 1.6× 193 1.0× 73 0.5× 102 0.9× 39 1.3k
Francesca Cordero Italy 24 588 1.2× 1.2k 2.5× 375 2.0× 138 0.9× 105 0.9× 82 1.8k
Bowen Xie China 18 389 0.8× 690 1.5× 292 1.5× 68 0.4× 84 0.7× 59 1.3k
Guowei Chen China 23 329 0.7× 670 1.5× 231 1.2× 115 0.7× 139 1.2× 67 1.3k
Galina Khramtsova United States 16 272 0.6× 844 1.9× 438 2.3× 77 0.5× 101 0.9× 34 1.5k
Jinxuan Hou China 16 397 0.8× 666 1.5× 415 2.2× 69 0.4× 146 1.2× 56 1.4k

Countries citing papers authored by Jinfeng Li

Since Specialization
Citations

This map shows the geographic impact of Jinfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Li more than expected).

Fields of papers citing papers by Jinfeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Li. The network helps show where Jinfeng Li may publish in the future.

Co-authorship network of co-authors of Jinfeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfeng Li. A scholar is included among the top collaborators of Jinfeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfeng Li. Jinfeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dai, Yi, Jinfeng Li, Yujiao Gao, et al.. (2023). Molecular Characterization and Marker Development of the HMW-GS Gene from Thinopyrum elongatum for Improving Wheat Quality. International Journal of Molecular Sciences. 24(13). 11072–11072. 5 indexed citations
4.
Chen, Xue, Yingjian He, Tao Ouyang, et al.. (2022). Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study. Technology in Cancer Research & Treatment. 21. 2213879104–2213879104. 2 indexed citations
5.
Wang, Xinguang, Zhaoqing Fan, Xing Wang, et al.. (2022). Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study. Breast Cancer Research and Treatment. 195(3). 301–310. 8 indexed citations
6.
Zhang, Panli, Peng Zou, Jinfeng Li, et al.. (2022). Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2. Molecular Therapy — Methods & Clinical Development. 26. 181–190. 1 indexed citations
8.
Su, Liming, Tao Ouyang, Jinfeng Li, et al.. (2021). Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers. Cancer Research. 81(10). 2600–2611. 48 indexed citations
9.
Liu, Fei, Chao Geng, Aiming Wang, et al.. (2020). Analysis of the population structure and genetic diversity of the red swamp crayfish (Procambarus clarkii) in China using SSR markers. Electronic Journal of Biotechnology. 47. 59–71. 15 indexed citations
11.
Xu, Ye, Lu Yao, Tao Ouyang, et al.. (2019). Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. International Journal of Cancer. 146(2). 487–495. 17 indexed citations
12.
Cao, Wei, Yingjian He, Jinfeng Li, et al.. (2018). Impact of adjuvant chemotherapy on the survival of patients with estrogen receptor≥50%, human epidermal growth factor receptor-2 negative, lymph node negative breast cancer. Zhonghua putong waike zazhi. 33(3). 223–227. 1 indexed citations
13.
Cheng, Hui, Jinfeng Li, Hong Zhang, et al.. (2017). The complete chloroplast genome sequence of strawberry ( Fragaria  ×  ananassa Duch.) and comparison with related species of Rosaceae. PeerJ. 5. e3919–e3919. 65 indexed citations
14.
Ouyang, Tao, Yuntao Xie, Tianfeng Wang, et al.. (2016). A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Breast Cancer Research and Treatment. 157(3). 527–534. 3 indexed citations
15.
Wang, Xinguang, Ling Huo, Yingjian He, et al.. (2016). Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound. Chinese Journal of Cancer Research. 28(5). 478–485. 26 indexed citations
16.
Wang, Yunliang, Yunliang Wang, Jinfeng Li, et al.. (2015). CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Letters. 367(2). 122–128. 215 indexed citations
17.
Ouyang, Tao, Tianfeng Wang, Yuntao Xie, et al.. (2015). [Safety of breast-conserving treatment for triple-negative breast cancer].. PubMed. 53(12). 947–52. 1 indexed citations
18.
19.
Li, Jinfeng, et al.. (2008). RAPD Analysis of Thirty-eight Cymbidium ensifolium Cultivars. Acta Horticulturae Sinica. 35(2). 289. 2 indexed citations
20.
Li, Jinfeng, et al.. (2004). Preoperative chemotherapy of continuous infusion of 5-fluorouracil, epirubicin or pirarubicin and cyclophosphamine in operable primary breast cancer. Chinese Journal of Cancer Research. 16(3). 197–202. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026